Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...
The label also alerts patients that the drug is associated with urinary retention ... Bristol Myers Squibb is continuing to study the drug for its longer term effects, as well as to understand and ...
The approval of this new label reflects the positive outcome of our ongoing and productive dialogue with the FDA, which shares our commitment to addressing unmet medical ... For more information ...
PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved VYALEV™ (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour ...
Wearable AF monitoring devices are extensively used in routine practice worldwide. The FDA has agreed on the use of AF monitoring devices in clinical trials for budiodarone approval. The FDA has ...